Expand LH Menu
LH MENU

LH Latest Press Releases

-- November 26, 2024 --

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients PRNewswire 7:52 AM

-- November 19, 2024 --

Labcorp CFO Glenn Eisenberg Announces Plans to Retire PRNewswire 7:00 AM

-- November 4, 2024 --

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience Business Wire 9:00 AM

-- October 24, 2024 --

Labcorp Announces 2024 Third Quarter Results PRNewswire 6:50 AM

-- October 18, 2024 --

Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors Business Wire 9:00 AM

-- October 16, 2024 --

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. Business Wire 8:00 AM

-- October 10, 2024 --

Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test PRNewswire 8:30 AM
Labcorp Declares Quarterly Dividend PRNewswire 6:50 AM

-- September 25, 2024 --

Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer Business Wire 11:19 AM

-- September 24, 2024 --

Labcorp to Announce Third Quarter Financial Results on October 24, 2024 PRNewswire 4:16 PM

-- September 18, 2024 --

Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience PRNewswire 7:00 AM

-- September 16, 2024 --

LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 PRNewswire 6:36 PM
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health PRNewswire 7:30 AM

-- September 3, 2024 --

Labcorp to Speak at the Baird 2024 Global Healthcare Conference PRNewswire 4:10 PM

-- August 5, 2024 --

Labcorp Finalizes Acquisition of Select Assets of Invitae PRNewswire 7:00 AM

-- August 2, 2024 --

Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx PRNewswire 8:30 AM

-- August 1, 2024 --

Labcorp Announces 2024 Second Quarter Results PRNewswire 6:58 AM

-- July 30, 2024 --

Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities PRNewswire 7:00 AM

-- July 25, 2024 --

Labcorp Declares Quarterly Dividend PRNewswire 6:59 AM